What Lancet Labs does

Lancet Laboratories (legally A C Mauff and Partners, operating as Lancet Labs) is one of South Africa's largest private diagnostic pathology laboratory networks, founded in 1960 and headquartered in Johannesburg. The company operates across all nine South African provinces and employs more than 100 specialist pathologists supporting a multi-discipline test menu that spans allergy, analytical chemistry, coagulation, cytogenetics, cytology, haematology, histology, microbiology, molecular pathology, TB, virology, and veterinary pathology. Its technology stack combines accredited laboratory instrumentation (ISO 15189 via SANAS, ISO 9001 certified support functions) with digital result-delivery platforms: the Lancet Lab Mobile App (available on Google Play, Apple App Store, and Huawei App Gallery) for patients and PathPortal V3 for referring physicians.

The business model is B2B2C and B2B: patients access services primarily through physician referrals, while corporate clients engage Lancet for occupational health and employee screening programmes, and insurance companies purchase medical underwriting testing. Revenue flows predominantly through South African medical aid schemes (including Discovery Health) and insurance payors, with cash-pay options for self-funded patients (e.g., COVID-19 PCR at R1,400). The company has also launched consumer-facing self-collection kits for HPV and colorectal screening, representing a direct-to-patient extension of the core lab offering.

In 2017, Lancet formed the Cerba Lancet Africa joint venture with France-based Cerba Healthcare — a European clinical pathology leader operating over 500 laboratories across 50+ countries with 7,000+ employees — to extend pathology services into 12 Sub-Saharan African markets (Botswana, Gabon, Ghana, Kenya, Mozambique, Rwanda, Nigeria, Eswatini, Tanzania, Uganda, Zimbabwe, Zambia). Lancet remains a privately-held partnership with no external institutional ownership, no public listing, and no recorded external funding rounds or M&A activity.

Name

Lancet Labs

Legal name

A C Mauff and Partners

Website

https://lancet.co.za

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Lancet Laboratories is a South African private diagnostic pathology network operating across all nine provinces, with more than 100 specialist pathologists serving private patients, physicians, corporate clients, and insurance companies. Through the Cerba Lancet Africa joint venture, it extends services to twelve additional African countries.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology Laboratory Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Veterinary Services (54194)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB), Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Occupational Health & Employer Testing Laboratories (HLAFAMAK), Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA), Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD), Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Diagnostic pathology services
• Medical laboratory testing
• Clinical diagnostics
• Specialty pathology tests
• Occupational health testing

Headquarters

HQ city

Johannesburg

HQ country

South Africa

HQ region

Africa

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Pathology Testing Services: Diagnostic pathology testing services for patients referred by healthcare providers. Services span multiple disciplines including chemistry, haematology, microbiology, virology, molecular pathology, cytogenetics, and histology. Revenue generated through medical aid schemes, insurance, and direct patient payments.
2. Corporate and Industrial Testing: Specialised pathology services for the corporate and industrial sectors, including occupational health testing and employee health screening programmes.
3. Insurance Medical Testing: Diagnostic testing services for insurance underwriting purposes including health assessments and medical evaluations.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Lancet Laboratories operates one of South Africa's largest pathology laboratory networks, providing diagnostic and monitoring pathology services across all nine provinces. The company offers a comprehensive test menu spanning allergy, chemistry, haematology, microbiology, molecular pathology, cytogenetics, histology, cytology, virology, and TB testing, delivered through physician referrals and supported by digital result delivery via the Lancet Lab Mobile Application and PathPortal V3 portal. Complementary offerings include occupational health services for corporate clients, insurance medical testing, parentage/DNA testing, and patient self-collection kits.

Product overview

Lancet Laboratories is a pathology laboratory network providing diagnostic and monitoring pathology services throughout South Africa (9 provinces) and across Africa through Cerba Lancet Africa. The company operates a portfolio of specialized pathology testing services including allergy, analytical chemistry, coagulation, cytogenetics, cytology, haematology, histology, microbiology, molecular pathology, TB, virology, and veterinary pathology. The core offering is complemented by digital health platforms including the Lancet Lab Mobile Application (available on Google Playstore, Apple iStore, and Huawei App Gallery) and PathPortal V3 for doctors to access results. Additional services include occupational health for corporate clients, insurance medical testing, and specialized testing such as parentage/paternity testing and HPV self-collection kits.

Differentiator

Problem solved

Functional benefit

Brands

• Cerba Lancet Africa: Joint venture brand providing pathology and diagnostic laboratory services across Sub-Saharan African markets including Botswana, Gabon, Ghana, Kenya, Mozambique, Rwanda, Nigeria, Eswatini, Tanzania, Uganda, Zimbabwe, and Zambia.

Products and services

• Allergy Testing Services Diagnostic testing services for identifying allergic conditions and sensitivities in patients referred by healthcare practitioners.
• Analytical Chemistry Services Laboratory analysis services for chemical substances and compounds in clinical samples, delivered through specialist technologists.
• Chemistry Services Routine and specialised chemistry diagnostic testing services for clinical decision-making.
• Coagulation Services Blood clotting and coagulation disorder diagnostic testing services.
• Cytogenetics Services Chromosomal analysis and genetic testing services for diagnosing hereditary conditions.
• Cytology Services Cell examination and analysis services for disease diagnosis.
• Haematology Services Blood disorders and blood-related disease diagnostic testing services.
• Histology Services Tissue examination and microscopic analysis services for disease diagnosis.
• Microbiology Services Infectious disease diagnostic testing including bacterial, viral, and fungal analysis.
• Molecular Pathology Services DNA/RNA-based diagnostic testing and molecular analysis services.
• TB Laboratory Services Specialised tuberculosis diagnostic testing services supporting public and private TB management.
• Virology Services Virus detection and analysis diagnostic testing services.
• Veterinary Pathology Services Animal health diagnostic testing services for veterinary practitioners.
• Occupational Health Services Workplace health screening and occupational wellness testing services for corporate clients.
• Insurance Medical Tests Medical assessment testing services for insurance underwriting and policy issuance purposes.
• Parentage Testing (Paternity/Maternity) DNA-based genetic testing for establishing biological parentage relationships.
• HPV & Colorectal Self-Collection Kit At-home sample collection kits for human papillomavirus and colorectal cancer screening.
• COVID-19 Testing Services Coronavirus diagnostic testing services including PCR testing, with cash price of R1,400 for self-pay patients.
• Semen Analysis Services Fertility assessment and reproductive health diagnostic testing services.
• Lancet Lab Mobile Application Mobile application enabling doctors and patients to access laboratory results from mobile devices, available on Google Playstore, Apple iStore, and Huawei App Gallery.
• PathPortal V3 Online portal enabling doctors to access and manage laboratory patient results digitally in real time.

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Cerba HealthcarecoreStrategic or Co-development PartnerCerba-Lancet Africa is a joint-venture between Cerba Healthcare of France and Lancet Laboratories of South Africa. Cerba Healthcare is a European leader in clinical pathology operating mainly in France, Belgium, Luxembourg and Italy through a network of over 500 laboratories and 50 technical facilities, servicing more than 50 countries in Europe, Africa and the Middle East.
• The Sunflower FundminorStrategic or Co-development PartnerPartnership for stem cell donor recruitment and HLA testing support. The Sunflower Fund is a non-profit organisation fighting blood diseases like Leukaemia through recruitment of stem cell donors.
• Lagitre International srlminorChannel Partner/ Reseller/ DistributorThermo Fisher's South African distributor for One Lambda products, supporting implementation of advanced HLA testing technology in South Africa.

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Regional players

• Metropolis Healthcare: Metropolis Healthcare is one of India's leading diagnostic laboratory chains with a multi-disciplinary test menu and pan-India presence plus international operations. Comparable as a regional pathology platform with similar multi-discipline testing and corporate/insurance segments, though focused on a different geography.
• Dr. Lal PathLabs: Dr. Lal PathLabs is a leading Indian diagnostic chain with a national network of laboratories and patient collection centres. Comparable as a regional pathology platform operating a similar multi-discipline, physician-referral-driven model, though serving a different geographic market.

Direct peers

• Cerba Lancet Africa: Cerba Lancet Africa is the joint-venture entity between Cerba Healthcare and Lancet Laboratories that delivers pathology services across 12 Sub-Saharan African countries. Directly overlaps with Lancet in geographic reach, test menu, and reference laboratory services in African markets outside South Africa.
• PathCare: PathCare is a major South African private pathology laboratory network offering comparable diagnostic services across chemistry, haematology, microbiology, and molecular pathology. Directly competes with Lancet for medical scheme contracts and physician referrals.
• Ampath: Ampath is one of the largest private pathology laboratory networks in South Africa, directly competing with Lancet for referring physician share across routine and specialised pathology testing. Both operate multi-province national footprints with similar test menus and medical-scheme-aligned revenue models.
• Cerba Healthcare: Cerba Healthcare is Lancet's joint-venture partner in Cerba Lancet Africa and one of Europe's leading clinical pathology operators, with 500+ laboratories across France, Belgium, Luxembourg and Italy. Operates the same reference laboratory model and shares the Africa expansion platform with Lancet.

Broad incumbents

• Synlab: Synlab is Europe's largest medical diagnostics services provider, operating clinical laboratories and reference testing centres across more than 30 countries. Comparable as a broad incumbent in clinical pathology with overlapping reference laboratory capabilities and corporate customer base.
• National Health Laboratory Service (NHLS): The NHLS is the largest pathology provider in South Africa, operating the public-sector laboratory network across all nine provinces. While focused on public-sector testing, NHLS competes indirectly with Lancet for pathologist talent and serves as a benchmark for pathology capacity in the same geography.
• Unilabs: Unilabs is a major European clinical laboratory and diagnostics provider operating across multiple specialties. Comparable as a broad incumbent offering overlapping routine and esoteric pathology services with cross-border reference laboratory capabilities.

Others

• Roche Diagnostics: Roche Diagnostics is a leading global supplier of in vitro diagnostic instruments, reagents, and consumables used by clinical laboratories including Lancet. Relevant as an enabling ecosystem participant providing the underlying technology platform upon which Lancet's chemistry, immunology, and molecular pathology services are built.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/CerbaLancetAfrica
• LinkedInlinkedin.com/company/lancet-laboratories

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lancet Labs